DiagnaMed Holdings Corp. (DMED) Stock Price & Analysis

9 Followers

DMED Stock Chart & Stats

CA$0.03-CA$0.00(-28.57%)

At close: Nov 10 4:00 PM EST

Day’s Range: CAD 0.03 - CAD 0.04
52-Week Range: CAD 0.03 - CAD 0.25
Previous Close: CAD 0.04
Volume: N/A
Average Volume (3M): 185.25K
Market Cap: CAD 3.29M
Enterprise Value: CAD 4.90M
Total Cash (Recent Filing): CAD 293.76K
Total Debt (Recent Filing): CAD 0
Price to Earnings (P/E): ―
Beta: 2.99
Next Earnings: Feb 02, 2027 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Bulls Say, Bears Say

Bulls Say

No Reported Debt

Absence of reported debt limits interest and repayment obligations, preserving more flexibility for a small company to direct scarce resources toward health-technology development. This is a relative balance-sheet advantage even though negative equity still weakens overall resilience.

Limited Non-Cash Distortion

Free cash flow is roughly in line with net income, indicating losses are not being driven by a large non-cash distortion. That makes the reported financial pressure more transparent for planning, although the company still needs funding because both measures remain negative.

Improving Negative Equity

Stockholders’ equity improved from approximately negative $450K in 2025 annual results to negative $178K on a TTM basis. The direction is constructive for balance-sheet repair, although equity remains negative and therefore does not yet provide a durable capital cushion.

Bears Say

Pre-Revenue Business

The absence of reported revenue means the company has not yet demonstrated commercial traction or an internally funded operating model. Without sales, future development must be supported by external financing, making progress toward sustainable profitability dependent on successful commercialization.

Worsening Losses

Losses have expanded materially over successive reporting periods, while operating profit and gross profit remain negative. This deterioration indicates weak operating leverage and raises the amount of capital required before the business can reach a self-sustaining earnings base.

Persistent Cash Burn

Persistent negative operating and free cash flow shows that the business consumes cash rather than generating it, and the larger TTM outflow indicates worsening funding needs. Continued burn can force reliance on external capital and restrict investment flexibility over the medium term.

DiagnaMed Holdings Corp. News

DiagnaMed reshapes board as it sharpens focus on natural clean hydrogen

The latest update is out from DiagnaMed Holdings Corp. ( ($TSE:DMED) ). DiagnaMed Holdings Corp. has appointed energy-law specialist Charles Turmel to its board, adding governance, regulatory and corporate finance

2M agoDMED

DiagnaMed Expands Natural Hydrogen Portfolio with Strategic Acquisition in Nova Scotia

DiagnaMed Holdings Corp. ( ($TSE:DMED) ) just unveiled an update. DiagnaMed Holdings Corp. has entered into an acquisition agreement to acquire the Colchester East Natural Hydrogen Project in Nova Scotia,

11M agoDMED

DiagnaMed Expands Hydrogen Zone in Ontario’s Témiscamingue Graben

DiagnaMed Holdings Corp. ( ($TSE:DMED) ) has issued an announcement. DiagnaMed Holdings Corp., in collaboration with Québec Innovative Materials Corp., has announced a significant expansion of the natural hydrogen system

1y agoDMED

DiagnaMed and QIMC Unveil Major Natural Hydrogen Discovery in Ontario

DiagnaMed Holdings Corp. ( ($TSE:DMED) ) just unveiled an update. DiagnaMed Holdings Corp. and Québec Innovative Materials Corp. have announced a significant natural hydrogen discovery in Ontario’s Témiscamingue Graben, marking

1y agoDMED

DiagnaMed Enhances Leadership Amid Key Exploration Milestone

DiagnaMed Holdings Corp. ( ($TSE:DMED) ) has provided an announcement. DiagnaMed Holdings Corp. has strengthened its leadership team with the appointment of André Turmel as Executive Chairman and Pam Sangster

1y agoDMED

DiagnaMed Advances Hydrogen Initiatives with Key Collaborations

DiagnaMed Holdings Corp. ( ($TSE:DMED) ) has issued an update. DiagnaMed Holdings Corp. has announced significant progress in its clean natural hydrogen soil sampling program in Northern Ontario, conducted in

1y agoDMED

DiagnaMed Aligns Leadership with Shareholders Through Equity Incentives

The latest update is out from DiagnaMed Holdings Corp. ( ($TSE:DMED) ). DiagnaMed Holdings Corp. has issued 3,000,000 restricted share units and 2,500,000 stock options to its directors, officers, and

1y agoDMED

DiagnaMed Announces CFO Transition Amidst Strategic Growth

DiagnaMed Holdings Corp. ( ($TSE:DMED) ) has shared an update. DiagnaMed Holdings Corp. announced a transition in its financial leadership, with Jing Peng stepping down as Chief Financial Officer and

1y agoDMED

DiagnaMed Launches Ontario Hydrogen Exploration and Strengthens Board

DiagnaMed Holdings Corp. ( ($TSE:DMED) ) has issued an update. DiagnaMed Holdings Corp. has announced a new hydrogen exploration campaign in Ontario, in collaboration with the Institut national de la

1y agoDMED

DiagnaMed Advances Hydrogen & Helium Exploration in Ontario

DiagnaMed Holdings Corp. ( ($TSE:DMED) ) just unveiled an announcement. DiagnaMed Holdings Corp. has advanced its Ontario Natural Hydrogen & Helium Program by strategically targeting geological zones in the Timiskaming

1y agoDMED

DMED FAQ

What was DiagnaMed Holdings Corp.’s price range in the past 12 months?

DiagnaMed Holdings Corp. lowest stock price was C$0.03 and its highest was C$0.25 in the past 12 months.

What is DiagnaMed Holdings Corp.’s market cap?

DiagnaMed Holdings Corp.’s market cap is C$3.29M.

When is DiagnaMed Holdings Corp.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were DiagnaMed Holdings Corp.’s earnings last quarter?

DiagnaMed Holdings Corp. released its earnings results on Jul 29, 2026. The company reported -C$0.01 earnings per share for the quarter.

Is DiagnaMed Holdings Corp. overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does DiagnaMed Holdings Corp. pay dividends?

DiagnaMed Holdings Corp. does not currently pay dividends.

What is DiagnaMed Holdings Corp.’s EPS estimate?

DiagnaMed Holdings Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does DiagnaMed Holdings Corp. have?

DiagnaMed Holdings Corp. has 131,559,310 shares outstanding.

What happened to DiagnaMed Holdings Corp.’s price movement after its last earnings report?

DiagnaMed Holdings Corp. reported an EPS of -C$0.01 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of DiagnaMed Holdings Corp.?

Currently, no hedge funds are holding shares in TSE:DMED

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description